Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 3,034	$ 1,272
Vendor advances, net	1,717	2,859
Prepaid expenses and other current assets	88	38
Total Current Assets	4,839	4,169
Deferred offering costs	1,692	1,377
Intangible assets, net	142	222
Total Other Assets	1,834	1,599
TOTAL ASSETS	6,673	5,768
Current Liabilities
Accounts payable and accrued expenses	676	992
Total Current Liabilities	676	992
Commitments and contingencies
Shareholders’ Equity
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 100,000,000 shares authorized; 17,743,765 and 13,736,597 shares issued and outstanding, respectively;	18	14
Additional paid-in capital	17,478	13,577
Accumulated deficit	(11,499)	(8,815)
Total Shareholders’ Equity	5,997	4,776
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 6,673	$ 5,768